Vir Biotechnology, Inc.VIRNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank25
3Y CAGR-96.5%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-96.5%/yr
vs +57.8%/yr prior
Acceleration
-154.3pp
Decelerating
Percentile
P25
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$26000.00-100.0%
2024$478.64M-16.4%
2023$572.83M-7.8%
2022$620.97M+20.8%
2021$513.87M-
2020$0.00-
2019$0.00-100.0%
2018$100.23M+60.3%
2017$62.51M-